JP2023508174A5 - - Google Patents
Info
- Publication number
- JP2023508174A5 JP2023508174A5 JP2022539176A JP2022539176A JP2023508174A5 JP 2023508174 A5 JP2023508174 A5 JP 2023508174A5 JP 2022539176 A JP2022539176 A JP 2022539176A JP 2022539176 A JP2022539176 A JP 2022539176A JP 2023508174 A5 JP2023508174 A5 JP 2023508174A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019127904 | 2019-12-24 | ||
| CNPCT/CN2019/127904 | 2019-12-24 | ||
| PCT/CN2020/138659 WO2021129672A1 (en) | 2019-12-24 | 2020-12-23 | Novel anti-fgfr2b antibodies |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023508174A JP2023508174A (ja) | 2023-03-01 |
| JP2023508174A5 true JP2023508174A5 (https=) | 2024-01-05 |
| JPWO2021129672A5 JPWO2021129672A5 (https=) | 2024-01-05 |
| JP7692419B2 JP7692419B2 (ja) | 2025-06-13 |
Family
ID=76575671
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022539176A Active JP7692419B2 (ja) | 2019-12-24 | 2020-12-23 | 新規抗ＦＧＦＲ２ｂ抗体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230052680A1 (https=) |
| EP (1) | EP4081547A4 (https=) |
| JP (1) | JP7692419B2 (https=) |
| KR (1) | KR20220119144A (https=) |
| CN (1) | CN114846029A (https=) |
| AR (1) | AR120886A1 (https=) |
| AU (1) | AU2020412088A1 (https=) |
| CA (1) | CA3160812A1 (https=) |
| MX (1) | MX2022007961A (https=) |
| TW (1) | TWI861326B (https=) |
| WO (1) | WO2021129672A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230052256A1 (en) * | 2019-12-24 | 2023-02-16 | Dizal (Jiangsu) Pharmaceutical Co., Ltd. | Novel anti-fgfr2b antibodies |
| AU2023243773A1 (en) * | 2022-03-28 | 2024-10-24 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Novel anti-fgfr2 antibodies. |
| WO2024199362A1 (en) * | 2023-03-31 | 2024-10-03 | Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. | Novel anti-FGFR2 antibodies |
| WO2024222912A1 (zh) * | 2023-04-28 | 2024-10-31 | 武汉人福创新药物研发中心有限公司 | 抗FGFR2b单抗 |
| CN118994393A (zh) * | 2023-05-19 | 2024-11-22 | 广东东阳光药业股份有限公司 | 一种抗fgfr2抗体及其应用 |
| TW202540177A (zh) * | 2023-11-14 | 2025-10-16 | 大陸商蘇州創勝醫藥集團有限公司 | 抗－ＦＧＦＲ２ｂ免疫偶聯物及其於治療癌症的用途 |
| WO2025130905A1 (zh) * | 2023-12-18 | 2025-06-26 | 山东先声生物制药有限公司 | 抗FGFR2b抗体-药物缀合物及其应用 |
| WO2025146131A1 (en) * | 2024-01-05 | 2025-07-10 | Beigene, Ltd. | ANTI-FGFR2b ANTIBODIES, CONJUGATES AND METHODS OF USE |
| CN120424212A (zh) * | 2024-01-26 | 2025-08-05 | 上海安领科生物医药有限公司 | 抗FGFR2b抗体及抗体药物偶联物 |
| CN118772279B (zh) * | 2024-06-28 | 2025-03-25 | 北京普利米特生物科技有限公司 | 抗FGFR2b抗体或其抗原结合片段及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7357928B2 (en) * | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
| AR044388A1 (es) * | 2003-05-20 | 2005-09-07 | Applied Molecular Evolution | Moleculas de union a cd20 |
| PL2365828T3 (pl) * | 2008-11-07 | 2015-04-30 | Galaxy Biotech Llc | Przeciwciała monoklonalne swoiste dla receptora 2 czynnika wzrostu fibroblastów |
| CN105263962B (zh) * | 2013-03-19 | 2019-12-31 | 北京盛诺基医药科技股份有限公司 | 抗体及用于治疗与雌激素受体相关疾病的方法 |
| PH12021552742A1 (en) * | 2013-08-01 | 2022-05-23 | Five Prime Therapeutics Inc | Afucosylated anti-fgfr2iiib antibodies |
| CN103757026B (zh) * | 2013-12-20 | 2017-04-05 | 广州圣露生物技术有限公司 | FGFR2b胞外段的基因序列、多肽及其应用 |
| US20170145103A1 (en) * | 2015-11-23 | 2017-05-25 | Five Prime Therapeutics, Inc. | Predicting response to cancer treatment with fgfr2 inhibitors |
| SG10202112636SA (en) * | 2017-05-16 | 2021-12-30 | Five Prime Therapeutics Inc | Anti-fgfr2 antibodies in combination with chemotherapy agents in cancer treatment |
-
2020
- 2020-12-23 MX MX2022007961A patent/MX2022007961A/es unknown
- 2020-12-23 KR KR1020227025532A patent/KR20220119144A/ko active Pending
- 2020-12-23 EP EP20904516.0A patent/EP4081547A4/en active Pending
- 2020-12-23 JP JP2022539176A patent/JP7692419B2/ja active Active
- 2020-12-23 CN CN202080090068.7A patent/CN114846029A/zh active Pending
- 2020-12-23 US US17/788,733 patent/US20230052680A1/en active Pending
- 2020-12-23 AU AU2020412088A patent/AU2020412088A1/en active Pending
- 2020-12-23 WO PCT/CN2020/138659 patent/WO2021129672A1/en not_active Ceased
- 2020-12-23 CA CA3160812A patent/CA3160812A1/en active Pending
- 2020-12-23 AR ARP200103630A patent/AR120886A1/es unknown
- 2020-12-24 TW TW109145975A patent/TWI861326B/zh active